Showing results (421-430 of 436) with videos related to
Sort By:
Pageof 44
European Journal of Biochemistry|October 15, 1996
Molecular characterization of a tissue-polypeptide-specific-antigen epitope and its relationship to human cytokeratin 18L Rydlander, E Ziegler, T Bergman, et al.Alimentary Pharmacology & Therapeutics|March 23, 2017
The dynamics of the oesophageal squamous epithelium 'normalisation' process in patients with gastro-oesophageal reflux disease treated with long-term acid suppression or anti-reflux surgeryL Mastracci, R Fiocca, C Engström, et al.The Journal of Urology|October 5, 2001
Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?B Djavan, V Ravery, A Zlotta, et al.Alimentary Pharmacology & Therapeutics|April 11, 2015
Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studiesS E Attwood, C Ell, J P Galmiche, et al.The Prostate|May 8, 2001
Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection studyB Djavan, P Mazal, A Zlotta, et al.Gut|October 8, 2008
Computed virtual chromoendoscopy versus standard colonoscopy with targeted indigocarmine chromoscopy: a randomised multicentre trialJ Pohl, E Lotterer, C Balzer, et al.The Journal of Urology|December 11, 2003
Multiphasic helical computerized tomography for the assessment of microscopic hematuria: a prospective studyE K Lang, R Thomas, R Davis, et al.Clinical Chemistry|April 2, 1999
Multicenter trial of the quantitative BTA TRAK assay in the detection of bladder cancerL Thomas, H Leyh, M Marberger, et al.Urology|July 22, 1998
Liarozole--a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate. Liarozole Study GroupF J Debruyne, R Murray, Y Fradet, et al.Pageof 44